The Valley Desk

NCT00085943 · Interventional trial

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Overall registry status Completed

Phase 3

Conditions HIV Infection, Infection, Human Immunodeficiency Virus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov